Skip to main content
. 2019 Jul 10;14(7):e0213222. doi: 10.1371/journal.pone.0213222

Table 1. Characteristics of participants in analysis (n = 243).

Age (n = 240)
Median Age (years) (IQR) (Range) 40 years (33, 48)
(Range: 22–67)
Number of participants (%) ≥50 years 48 (20.0%)
Gender (n = 243) Number (%)
    Male 243 (100.0%)
Ethnicity (n = 241)
White 213 (88.4%)
Black Caribbean or Black African 6 (2.5%)
Indian, Pakistani or Chinese 5 (2.1%)
Other 17 (7.1%)
Nationality (n = 243)
United Kingdom of Great Britain and Northern Ireland 143 (58.8%)
European Union (e.g. France, Italy, Ireland, Spain, Poland, Greece, Portugal, Germany) 75 (30.9%)
United States, North America 8 (3.3%)
South America 4 (1.6%)
Asia-Pacific Region 8 (3.3%)
Other (Middle East, or Africa) 5 (2.1%)
Sexuality (n = 243)
Homosexual 234 (96.3%)
Heterosexual, bisexual, unknown 9 (3.7%)
Smoking Status (n = 237)
Current Smoker 58 (24.5%)
Participants’ household description: I am living…. (n = 238)
Alone 83 (34.9%)
With a spouse or partner 81 (34.0%)
With a flatmate/friend 65 (27.3%)
Other (e.g. living with a child <18 years, living in an institutionalised residence or care home) 9 (3.8%)
Employment status (n = 242)
Employed: regular, occasional/part-time employment, self-employed, freelance 210 (86.8%)
Not employed: Benefits (including Disability Living Allowance and Employment Support Allowance) 12 (5.0%)
Not Employed: Income from savings, investments or pension 15 (6.2%)
Support from spouse, parents, children, relatives, or friends 5 (2.1%)
Highest level of education completed (n = 243)
University 177 (72.8%)
College/vocational training 48 (19.8%)
Secondary 18 (7.4%)
Year of HIV diagnosis (n = 241)
Median Year of HIV Diagnosis (IQR)(Range) 2012 (2007, 2014)
(Range: 1983–2016)
Diagnosed in 1996 or after 231(95.9%)
Taking antiretroviral therapy (n = 242)
Yes 228 (94.2%)
CD4 Count (cells/mm3) (n = 239)
Median (IQR) (Range) Median: 676 (508, 875)
Range: 190–7545
Viral Load (n = 236)
Undetectable (<40 cells/ml) 193 (81.8%)
Registered with General Physician (GP) (n = 243)
    Yes 214 (88.1%)
Concurrent Health Conditions* (n = 241)
Diagnosed with other medical condition 130 (53.9%)
Living with ≥2 concurrent health conditions 52 (21.6%)
Diagnosed with concurrent mental health condition (eg: anxiety, depression, personality disorder or schizophrenia) 20 (8.3%)
Diagnosed with concurrent malignancy, opportunistic infection, or immune reconstitution inflammatory syndrome 18 (7.5%)
Diagnosed with concurrent hypertension 18 (7.5%)

IQR: Interquartile Range

*as determined from the electronic health record.